Updating the Canadian clinical practice guideline for managing pediatric obesity: a protocol

Bradley C Johnston1, Roah Merdad1, Diana Sherifali1

  • 1Departments of Nutrition and of Epidemiology and Biostatistics (Johnston), Texas A&M University, College Station, Tex.; Department of Community Health and Epidemiology (Johnston, Merdad), Dalhousie University, Halifax, NS; School of Nursing (Sherifali), McMaster University, Hamilton, Ont.; Pennington Biomedical Research Center (Kebbe), Louisiana State University, Baton Rouge, La.; Department of Paediatrics (Birken, Hamilton), University of Toronto, Toronto, Ont.; Children's Hospital of Eastern Ontario Research Institute (Buchholz), Ottawa, Ont.; Department of Psychology (Buchholz), Carleton University, Ottawa, Ont.; Evidence-based Social Science Research Centre (Ge), School of Public Health, Lanzhou University, Lanzhou, China; School of Public Health (Gehring), University of Alberta, Edmonton, Alta.; Department of Pediatrics (Hadjiyannakis), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Obesity Canada (Hatanaka, Ramos Salas), Edmonton, Alta.; Department of Pediatrics (Henderson), Université de Montréal, Montréal, Que.; Centre de recherche du Centre hospitalier universitaire Sainte-Justine (Henderson), Montréal, Que.; Department of Social and Preventive Medicine (Henderson), School of Public Health, Université de Montréal, Montréal, Que.; patient and family partner (Lebel), Edmonton, Alta.; School of Health & Human Performance (Moore), Faculty of Health, Dalhousie University, Halifax, NS; Department of Pediatrics (Morrison), McMaster University, Hamilton, Ont.; Department of Pediatrics (Sebastianski, Ball), University of Alberta, Edmonton, Alta.; Institute for Better Health (Zenlea), Trillium Health Partners, Mississauga, Ont.

CMAJ Open
|March 2, 2022
PubMed

Insights

This study outlines the protocol for updating Canada's pediatric obesity management guidelines, incorporating new evidence and standards for better clinical decisions.

Area of Science:

  • Public Health
  • Clinical Practice Guidelines
  • Pediatric Endocrinology

Background:

  • The 2007 Canadian clinical practice guideline for obesity management requires updating due to new evidence and evolving standards.
  • This protocol focuses on revising the pediatric components of the existing guideline.

Purpose of the Study:

  • To describe the protocol for updating the Canadian clinical practice guideline for managing pediatric obesity.
  • To ensure informed, value-sensitive, and evidence-based clinical decisions for pediatric obesity management.

Main Methods:

  • The guideline update follows National Academy of Medicine and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) standards.
  • Five literature reviews (one scoping, four systematic) will synthesize evidence on assessment, values, preferences, and intervention safety/effectiveness.
  • Standard systematic review methodology will be employed, including evidence certainty assessment and recommendation strength determination.

Main Results:

  • This protocol aims to produce an updated, evidence-based clinical practice guideline for pediatric obesity management in Canada.
  • The guideline will be developed with input from diverse stakeholders, including families and clinicians.
  • Knowledge translation strategies will be used for optimal dissemination.

Conclusions:

  • The updated guideline will support Canadian healthcare providers and families in making informed decisions regarding pediatric obesity.
  • The guideline will be published in English and French, with resources for end-users.
  • Partnership with Obesity Canada will enhance dissemination and knowledge translation efforts.
Abstract

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
735
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
774
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
643
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
667
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
914
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.9K